WellCare price target raised to $275 from $235 at Cantor Fitzgerald. Cantor Fitzgerald analyst Steven Halper raised his price target for WellCare to $275 after including the pending Meridian acquisition into his 2019 estimates. The Meridian acquisition makes sense strategically and financially and should close at the end of 2018, Halper tells investors in a research note. He’s positive on the deal and reiterates an Overweight rating on WellCare.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.